Evidence map›Paper›PMID 34357132›Full record

ReviewJournal of personalized medicine2021

Retinal Vascular Signs as Screening and Prognostic Factors for Chronic Kidney Disease: A Systematic Review and Meta-Analysis of Current Evidence.

Michael Aronov, Raviv Allon, Danielle Stave, Michael Belkin, Eyal Margalit, Ido Didi Fabian, Barak Rosenzweig

Open access · goldAbstract readReview
In one paragraph

Review in Journal of personalized medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 2 pooled it
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 2 syntheses or guidelines pooled it, 25 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Systemic Diseases and the Eye: A Translational Perspective on Diabetes.Chronic diseases and translational medicine · 2026
    Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Schizophrenia in Translation: Why the Eye?Schizophrenia bulletin · 2022
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Michael AronovSPRING Biomed Vision Ltd. 8, Haneviim St., Haifa 3350109, Israel.
Raviv AllonSPRING Biomed Vision Ltd. 8, Haneviim St., Haifa 3350109, Israel.ORCID 0000-0001-6639-9219
Danielle StaveSPRING Biomed Vision Ltd. 8, Haneviim St., Haifa 3350109, Israel.
Michael BelkinThe Goldschleger Eye Institute, Sheba Medical Center, Tel Hashomer 5262000, Israel.
Eyal MargalitSPRING Biomed Vision Ltd. 8, Haneviim St., Haifa 3350109, Israel.
Ido Didi FabianThe Goldschleger Eye Institute, Sheba Medical Center, Tel Hashomer 5262000, Israel.ORCID 0000-0002-0846-5131
Barak RosenzweigSackler Faculty of Medicine, Tel Aviv University, Tel Aviv 69978, Israel.
Tel Aviv University · IL

Funding

SPRING Biomed Vision Ltd.
6 · The paper itself

Abstract

backgroundThe substantial burden of kidney disease fosters interest in new ways of screening for early disease diagnosis, especially by non-invasive imaging. Increasing evidence for an association between retinal microvascular signs and kidney disease prompted us to investigate the relevant current literature on such an association systematically by performing a meta-analysis of our findings.

methodsWe scrutinized the current literature by searching PubMed and Embase databases from for clinical studies of the association between retinal microvascular signs and prevalent or incident kidney disease. After excluding cases that did not meet our criteria, we extracted relevant data from 42 published studies (9 prospective, 32 cross-sectional, and 1 retrospective).

resultsOur investigation yielded significant associations between retinal vascular changes (including retinopathy and retinal vascular diameter) and kidney dysfunction (including chronic kidney disease (CKD), end-stage renal disease (ESRD), albuminuria, and estimated glomerular filtration rate (eGFR) decline). According to our meta-analysis, retinopathy was associated with ESRD (hazard ratio (HR) 2.12 (95% confidence interval CI; 1.39-3.22)) and with CKD prevalence in the general population (odds ratio (OR) 1.31 (95% CI; 1.14-1.50)), and specifically in type 2 diabetic patients (OR 1.68 (95% CI; 1.68-2.16)). CRAE was associated with prevalent CKD (OR 1.41 (95% CI; 1.09-1.82)).

conclusionsOur findings suggest that the retinal microvasculature can provide essential data about concurrent kidney disease status and predict future risk for kidney disease development and progression.

Indexed as

chronic kidney diseasediabetic retinopathyend-stage renal diseasefundus photographyglomerular filtration rateretinal vascular diameter

Identifiers

PMID34357132
PMCPMC8307097
OpenAlexW3180536597

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.